Cathie Woods ARK sells Teladoc and Zoom, buys Roku and 10x Genomics stock By Investing.com - Investing.com
| SXYAY Stock | USD 26.61 0.12 0.45% |
Slightly above 55% of Sika AG's investor base is interested to short. The analysis of overall sentiment of trading Sika AG ADR pink sheet suggests that many investors are impartial at this time. Sika AG's investing sentiment can be driven by a variety of factors including economic data, Sika AG's earnings reports, geopolitical events, and overall market trends.
Sika |
Cathie Woods ARK sells Teladoc and Zoom, buys Roku and 10x Genomics stock By Investing.com Investing.com
Read at news.google.com
 |
Sika AG Fundamental Analysis
We analyze Sika AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sika AG using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sika AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Sika AG is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Sika AG ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sika AG pink sheet to make a market-neutral strategy. Peer analysis of Sika AG could also be used in its relative valuation, which is a method of valuing Sika AG by comparing valuation metrics with similar companies.
Peers
Sika AG Related Equities
| KBLB | Kraig Biocraft | 9.09 | ||||
| APD | Air Products | 0.45 | ||||
| NVZMY | Novozymes | 0.46 | ||||
| IFF | International Flavors | 0.65 | ||||
| SYIEY | Symrise Ag | 1.14 | ||||
| GVDNY | Givaudan | 1.21 | ||||
| SHW | Sherwin Williams | 1.29 | ||||
| NVZMF | Novozymes | 1.95 | ||||
| GVDBF | Givaudan | 1.99 | ||||
| SKFOF | Sika AG | 2.47 | ||||
| ALB | Albemarle Corp | 5.18 |
Additional Tools for Sika Pink Sheet Analysis
When running Sika AG's price analysis, check to measure Sika AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sika AG is operating at the current time. Most of Sika AG's value examination focuses on studying past and present price action to predict the probability of Sika AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sika AG's price. Additionally, you may evaluate how the addition of Sika AG to your portfolios can decrease your overall portfolio volatility.